Analyze Diet
Vaccine2005; 24(4); 516-524; doi: 10.1016/j.vaccine.2005.07.083

Analysis of yearly changes in levels of antibodies to Japanese encephalitis virus nonstructural 1 protein in racehorses in central Japan shows high levels of natural virus activity still exist.

Abstract: Recent reductions in numbers of human and equine Japanese encephalitis (JE) cases in Japan have seen calls to end JE vaccination. Here, we analyzed yearly variations of natural JE virus activity, using sera collected serially in 1998-2003 from racehorses residing in Ibaraki and Shiga prefectures, both located in central Japan. A total of 208 sera from 24 individuals in Ibaraki and 259 from 27 in Shiga were examined for antibodies to JE virus nonstructural 1 (NS1) protein, a marker of natural infection. The natural infection rate in epizootic seasons, which was determined by a significant increase in NS1 antibody level, was 4.2-26.7% in Ibaraki and 0-41.7% in Shiga, indicating that high levels of JE virus activity still existed in central Japan.
Publication Date: 2005-08-11 PubMed ID: 16129523DOI: 10.1016/j.vaccine.2005.07.083Google Scholar: Lookup
The Equine Research Bank provides access to a large database of publicly available scientific literature. Inclusion in the Research Bank does not imply endorsement of study methods or findings by Mad Barn.
  • Journal Article
  • Research Support
  • Non-U.S. Gov't

Summary

This research summary has been generated with artificial intelligence and may contain errors and omissions. Refer to the original study to confirm details provided. Submit correction.

This research investigates the prevalence of the Japanese Encephalitis (JE) virus in horse populations in central Japan from 1998 to 2003. Despite reduced occurrences of JE in humans and horses in Japan that prompted calls to end immunization, the researchers found high occurrences of the virus in horses, indicating continued significant natural activity of the virus.

Methodology

  • The researchers carried out their analysis by studying variations in the natural activity of the JE virus annually. This was achieved by using sera collected serially from 1998 to 2003. The sera were sampled from racehorses that lived in either of two prefectures in central Japan: Ibaraki and Shiga.
  • A combined total of 467 sera were examined. This included 208 samples from 24 individuals in Ibaraki and 259 samples from 27 individuals in Shiga.
  • The team scrutinized these sera for antibodies to the JE virus nonstructural 1 (NS1) protein. Notably, these antibodies are markers of natural infection, meaning that their presence in the sera would indicate that the horses had been naturally infected with the JE virus.

Findings

  • The researchers found that there were significant variances in the natural infection rate during the epizootic seasons. These rates were determined through observation of a significant boost in NS1 antibody level.
  • In Ibaraki, the infection rate oscillated between 4.2% and 26.7%. In Shiga, the rate ranged from 0% to as high as 41.7%.
  • This variation indicates that there is still a high level of JE virus activity in the regions where the racehorses resided. Hence, in spite of the declines in the number of JE cases in humans and horses, the study suggests that the virus has not been eradicated in these areas.

Implications

  • The study’s results have significant implications in shaping public health policy. They challenge the calls to end JW vaccination after the observed reduction in human and horse cases. The virus’ natural infection rates in these horse populations suggest that the JE virus is still widely active.
  • The study stresses the importance of continued vigilance against the JE virus, and suggests that ending vaccination might not be advisable at this stage, given these high levels of viral activity.

Cite This Article

APA
Konishi E, Shoda M, Kondo T. (2005). Analysis of yearly changes in levels of antibodies to Japanese encephalitis virus nonstructural 1 protein in racehorses in central Japan shows high levels of natural virus activity still exist. Vaccine, 24(4), 516-524. https://doi.org/10.1016/j.vaccine.2005.07.083

Publication

ISSN: 0264-410X
NlmUniqueID: 8406899
Country: Netherlands
Language: English
Volume: 24
Issue: 4
Pages: 516-524

Researcher Affiliations

Konishi, Eiji
  • Department of Health Sciences, Kobe University School of Medicine, 7-10-2 Tomogaoka, Suma-ku, Kobe 654-0142, Japan. ekon@ams.kobe-u.ac.jp
Shoda, Mizue
    Kondo, Takashi

      MeSH Terms

      • Animals
      • Antibodies, Viral / analysis
      • Encephalitis Virus, Japanese / physiology
      • Encephalitis, Japanese / immunology
      • Encephalitis, Japanese / prevention & control
      • Encephalitis, Japanese / veterinary
      • Enzyme-Linked Immunosorbent Assay
      • Horse Diseases / epidemiology
      • Horse Diseases / immunology
      • Horse Diseases / prevention & control
      • Horses
      • Japan / epidemiology
      • Japanese Encephalitis Vaccines / immunology
      • Viral Nonstructural Proteins / immunology

      Citations

      This article has been cited 6 times.
      1. Yun SI, Lee YM. Early Events in Japanese Encephalitis Virus Infection: Viral Entry. Pathogens 2018 Aug 13;7(3).
        doi: 10.3390/pathogens7030068pubmed: 30104482google scholar: lookup
      2. Wang H, Liang G. Epidemiology of Japanese encephalitis: past, present, and future prospects. Ther Clin Risk Manag 2015;11:435-48.
        doi: 10.2147/TCRM.S51168pubmed: 25848290google scholar: lookup
      3. Cleton NB, Godeke GJ, Reimerink J, Beersma MF, Doorn HR, Franco L, Goeijenbier M, Jimenez-Clavero MA, Johnson BW, Niedrig M, Papa A, Sambri V, Tami A, Velasco-Salas ZI, Koopmans MP, Reusken CB. Spot the difference-development of a syndrome based protein microarray for specific serological detection of multiple flavivirus infections in travelers. PLoS Negl Trop Dis 2015 Mar;9(3):e0003580.
        doi: 10.1371/journal.pntd.0003580pubmed: 25767876google scholar: lookup
      4. Bielefeldt-Ohmann H, Prow NA, Wang W, Tan CS, Coyle M, Douma A, Hobson-Peters J, Kidd L, Hall RA, Petrovsky N. Safety and immunogenicity of a delta inulin-adjuvanted inactivated Japanese encephalitis virus vaccine in pregnant mares and foals. Vet Res 2014 Dec 17;45(1):130.
        doi: 10.1186/s13567-014-0130-7pubmed: 25516480google scholar: lookup
      5. Prow NA, Tan CS, Wang W, Hobson-Peters J, Kidd L, Barton A, Wright J, Hall RA, Bielefeldt-Ohmann H. Natural exposure of horses to mosquito-borne flaviviruses in south-east Queensland, Australia. Int J Environ Res Public Health 2013 Sep 17;10(9):4432-43.
        doi: 10.3390/ijerph10094432pubmed: 24048209google scholar: lookup
      6. Kitai Y, Shoda M, Kondo T, Konishi E. Epitope-blocking enzyme-linked immunosorbent assay to differentiate west nile virus from Japanese encephalitis virus infections in equine sera. Clin Vaccine Immunol 2007 Aug;14(8):1024-31.
        doi: 10.1128/CVI.00051-07pubmed: 17596430google scholar: lookup